Difference between revisions of "Talk:Assessment of the health impacts of H1N1 vaccination"
From Testiwiki
(Pandemrix should not be used because of narcolepsy risk) |
m |
||
Line 10: | Line 10: | ||
:{{defend|3 |In Finland, THL decided to stop the use of Pandemrix.|--[[User:Jouni|Jouni]] 23:05, 31 March 2011 (EEST), [http://www.thl.fi/fi_FI/web/fi/uutinen?id{{eq}}22930]}} | :{{defend|3 |In Finland, THL decided to stop the use of Pandemrix.|--[[User:Jouni|Jouni]] 23:05, 31 March 2011 (EEST), [http://www.thl.fi/fi_FI/web/fi/uutinen?id{{eq}}22930]}} | ||
}} | }} | ||
+ | |||
+ | '''Discussion groups: | ||
+ | * [[Talk:Assessment of the health impacts of H1N1 vaccination/Group A]] | ||
+ | * [[Talk:Assessment of the health impacts of H1N1 vaccination/Group B]] | ||
+ | * [[Talk:Assessment of the health impacts of H1N1 vaccination/Group C]] | ||
+ | * [[Talk:Assessment of the health impacts of H1N1 vaccination/Group D]] | ||
+ | * [[Talk:Assessment of the health impacts of H1N1 vaccination/Group E]] |
Revision as of 21:08, 31 March 2011
Pandemrix should not be used because of narcolepsy risk
Statements: Pandemrix should not be used any more anywhere because its narcolepsy risk is too high.
Resolution: Resolution not yet found. (A stable resolution, when found, should be updated to the main page.) |
Argumentation:
⇤1 : Despite risks, Pandemrix is an effective vaccine and has clearly net positive effects in countries where emergency treatment is poorly available for severe swine flu cases. --Jouni 23:05, 31 March 2011 (EEST) ←2 : The reputation of Pandemrix is globally so poor that it is impossible to use it any more. --Jouni 23:05, 31 March 2011 (EEST) |
Discussion groups:
- Talk:Assessment of the health impacts of H1N1 vaccination/Group A
- Talk:Assessment of the health impacts of H1N1 vaccination/Group B
- Talk:Assessment of the health impacts of H1N1 vaccination/Group C
- Talk:Assessment of the health impacts of H1N1 vaccination/Group D
- Talk:Assessment of the health impacts of H1N1 vaccination/Group E